Regeneron Pharmaceuticals, Inc. (REGN): Capital Expenditures
$898.40M
Year ended 2025-12-31
$920.90M
Trailing 12 months to 2026-06-30
+15.0%
3-year compound annual growth
+7.9%
5-year compound annual growth
+2.9%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $898.40M | +18.9% | 2026-02-04, From 2025-01-01 |
| 2024-12-31 | $755.90M | +5.2% | 2026-02-04, From 2024-01-01 |
| 2023-12-31 | $718.60M | +21.8% | 2026-02-04, From 2023-01-01 |
| 2022-12-31 | $590.10M | +6.9% | 2025-02-05, From 2022-01-01 |
| 2021-12-31 | $551.90M | -10.2% | 2024-02-05, From 2021-01-01 |
| 2020-12-31 | $614.60M | +43.1% | 2023-02-06, From 2020-01-01 |
| 2019-12-31 | $429.60M | +12.1% | 2022-02-07, From 2019-01-01 |
| 2018-12-31 | $383.10M | +40.5% | 2021-02-08, From 2018-01-01 |
| 2017-12-31 | $272.60M | -46.7% | 2020-02-07, From 2017-01-01 |
| 2016-12-31 | $511.90M | -24.5% | 2019-02-07, From 2016-01-01 |
| 2015-12-31 | $677.93M | +103.6% | 2018-02-08, From 2015-01-01 |
| 2014-12-31 | $333.01M | +113.0% | 2017-02-09, From 2014-01-01 |
| 2013-12-31 | $156.32M | +216.8% | 2016-02-11, From 2013-01-01 |
| 2012-12-31 | $49.34M | -13.8% | 2015-02-12, From 2012-01-01 |
| 2011-12-31 | $57.22M | -42.6% | 2014-02-13, From 2011-01-01 |
| 2010-12-31 | $99.69M | +2.4% | 2013-02-15, From 2010-01-01 |
| 2009-12-31 | $97.32M | +179.2% | 2012-02-21, From 2009-01-01 |
| 2008-12-31 | $34.86M | n/a | 2011-02-17, From 2008-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $898.40M | +18.9% |
| Viatris Inc (VTRS) | 2025-12-31 | $378.80M | +16.2% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $437.60M | +47.0% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $501.00M | +0.6% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $397.00M | +17.8% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $621.00M | -5.2% |
| Organon & Co. (OGN) | 2025-12-31 | $162.00M | -7.4% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $185.84M | -62.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $276.00M | +87.8% |
Compare REGN, VTRS, VRTX, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗